HY-133511-100mg
|
MedChemexpress LLC
|
MLS000544460 [CAS 352336-36-8]
|
|
Cancer-programmed cell death
|
|
HY-133511-25mg
|
MedChemexpress LLC
|
MLS000544460 [CAS 352336-36-8]
|
|
Cancer-programmed cell death
|
|
HY-133511-5mg
|
MedChemexpress LLC
|
MLS000544460 [CAS 352336-36-8]
|
|
Cancer-programmed cell death
|
|
HY-133511-50mg
|
MedChemexpress LLC
|
MLS000544460 [CAS 352336-36-8]
|
|
Cancer-programmed cell death
|
|
HY-133511-1mL
|
MedChemexpress LLC
|
MLS000544460 [CAS 352336-36-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-123846-10mg
|
MedChemexpress LLC
|
MLS-0437605 [CAS 862975-18-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-123846-100mg
|
MedChemexpress LLC
|
MLS-0437605 [CAS 862975-18-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-123846-25mg
|
MedChemexpress LLC
|
MLS-0437605 [CAS 862975-18-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-123846-5mg
|
MedChemexpress LLC
|
MLS-0437605 [CAS 862975-18-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-123846-50mg
|
MedChemexpress LLC
|
MLS-0437605 [CAS 862975-18-6]
|
|
Neuroscience-Neuromodulation
|
|
HY-123846-1mL
|
MedChemexpress LLC
|
MLS-0437605 [CAS 862975-18-6] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
HY-N2111-1mg
|
MedChemexpress LLC
|
Momordicoside A [CAS 75801-95-5]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-N2111-5mg
|
MedChemexpress LLC
|
Momordicoside A [CAS 75801-95-5]
|
|
Metabolism-sugar/lipid metabolism
|
|